Today: 19 April 2026
The Trade Desk stock jumps after report of OpenAI ad talks and CEO Jeff Green’s $148 million buy
6 March 2026
1 min read

The Trade Desk stock jumps after report of OpenAI ad talks and CEO Jeff Green’s $148 million buy

NEW YORK, March 6, 2026, 7:10 EST

Shares of Trade Desk surged about 18% around 6:52 a.m. EST Friday. The move came after news broke that OpenAI recently held early talks with the ad tech company over a possible partnership on ad sales.

The Trade Desk put out a Q1 revenue forecast of at least $678 million, but that wasn’t enough to satisfy investors. Reuters reported the stock fell 4.8% on Feb. 26, as competitive pressure from larger rivals mounted. The ad-tech firm posted $847 million in revenue for the fourth quarter and secured $2.9 billion heading into 2025. But the market focused on the cautious guidance, which triggered the sell-off.

OpenAI isn’t wasting time. As of February 9, ads began surfacing in ChatGPT for logged-in U.S. adults on the Free and Go plans, while paid tiers remain untouched by advertising. The company says these spots are always labeled, don’t touch answer quality, and are there to help fund broader access.

The Trade Desk offers brands and agencies a way to buy ad slots across digital platforms—think websites, mobile apps, even connected TVs—via automated auctions. A filing with the U.S. Securities and Exchange Commission shows Chief Executive Jeff Green acquired 6 million shares over March 2 to March 4, shelling out between $23.49 and $25.08 apiece on a weighted average basis. Altogether, Green spent roughly $148.1 million.

Green posted $2.9 billion in revenue for 2025, according to its February 25 earnings release. Executives pointed to “a backdrop of macro uncertainty” as they navigated the period. Adjusted EBITDA for the first quarter came in at about $195 million, falling short of Wall Street estimates, the filing shows. SEC

Some analysts flagged the OpenAI link as promising, but not without reservations. “Generative AI engines could be a significant source of incremental gross spend,” Mark Mahaney at Evercore ISI said. Over at D.A. Davidson, Tom White noted that direct, programmatic access for Trade Desk’s clients to ChatGPT ad inventory would be a clear positive. Investors

Criteo surged ahead on March 2, claiming it was the first ad-tech company to join OpenAI’s ChatGPT advertising pilot in the U.S. That suggests OpenAI is testing out multiple approaches as it seeks new sources of revenue; Reuters reported this week that OpenAI’s annualized revenue hit $25 billion as of last month.

Any upside could prove short-lived—or just underwhelming. As OpenAI’s help page spells out, ads and their controls currently reach only Free and Go users in the U.S. Barron’s noted The Trade Desk had no comment, and OpenAI stayed quiet, at least for now. If OpenAI sticks to building this in-house, the near-term payoff is shaping up to be less than traders first imagined.

Stock Market Today

  • D-Wave Quantum Stock Forecast and Current Market Interest
    April 19, 2026, 1:35 AM EDT. Interest in D-Wave Quantum is rising as investors watch developments in quantum computing. D-Wave specializes in quantum annealing, a method for solving complex optimization problems faster than traditional computers. Market enthusiasm is driven by potential applications in sectors like logistics and pharmaceuticals. However, the stock remains volatile due to technological uncertainties and competition. Experts advise caution and recommend consulting financial professionals before investing in this emerging tech space.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.04.2026

19 April 2026
LIVEMarkets rolling coverageStarted: April 19, 2026, 12:00 AM EDTUpdated: April 19, 2026, 1:35 AM EDT D-Wave Quantum Stock Forecast and Current Market Interest April 19, 2026, 1:35 AM EDT. Interest in D-Wave Quantum is rising as investors watch developments in quantum computing. D-Wave specializes in quantum annealing, a method for solving complex optimization problems faster than traditional computers. Market enthusiasm is driven by potential applications in sectors like logistics and pharmaceuticals. However, the stock remains volatile due to technological uncertainties and competition. Experts advise caution and recommend consulting financial professionals before investing in this emerging tech space. AES (NYSE:AES) Stock
Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Aviva kicks off £350m share buyback after profit jump and bigger dividend
Previous Story

Aviva kicks off £350m share buyback after profit jump and bigger dividend

Banco Bradesco S.A. Pushes R$52 Billion Bradsaúde Plan Toward March 31 Vote
Next Story

Banco Bradesco S.A. Pushes R$52 Billion Bradsaúde Plan Toward March 31 Vote

Go toTop